Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.570, 2009-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Botox injects meaningful improvements into QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640, 2011-01 ,pp. :
Access to resources
Recommend
Measuring QOL in patients with acne
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 284, 2000-01 ,pp. :
Measuring QOL in rheumatoid arthritis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 263, 2000-01 ,pp. :
Thyroxine plus liothyronine: no QOL benefit
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 439, 2003-01 ,pp. :
No long-term QOL benefit for CRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :